Search - tctmd.com

Displaying 61 - 80 of 146

Sort: Relevancy | Date

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

Presentation TCT 2019

Republic of Korea Presents: Thoracic Aorta Dissection by Sheath Catheter of SAPIEN 3 During TAVI Stabilized by Conservative Measure

Presenter: Hyo-Soo Kim

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Presentation TCT 2018

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

Presenter: Charles J. Davidson, Francesco Maisano, Raj Makkar

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Henryk Dreger

September 21, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

Presentation TCT 2017

How to Treat Severe PR in the Large RVOT Using Melody or Sapien Valves

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Daniel S Levi

November 01, 2017

Presentation TCT 2017

Current Results of Transcatheter PV Therapy: Melody and Sapien

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Thomas K. Jones

November 01, 2017

Presentation TCT 2017

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

Presenter: Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Presenter: John G. Webb

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Advertisement

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Republic of Korea Presents: Thoracic Aorta Dissection by Sheath Catheter of SAPIEN 3 During TAVI Stabilized by Conservative Measure

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

How to Treat Severe PR in the Large RVOT Using Melody or Sapien Valves

Current Results of Transcatheter PV Therapy: Melody and Sapien

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Live From Denver: TCT 2017, Day Two

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content